Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

dimethyl sulfoxide

EU orphan designation number: EU/3/05/263   
Active ingredient: dimethyl sulfoxide
Indication: Treatment of severe closed traumatic brain injury
Sponsor: AOP Orphan Pharmaceuticals AG
Wilhelminenstraβe 91/II f, 1160 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
7/03/2005 Orphan designation EMEA/OD/082/04 (2005)573 of 3/03/2005